These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 8738500)
1. Prognostic significance of nuclear DNA content in human meningiomas: a prospective study. Meixensberger J; Janka M; Zellner A; Roggendorf W; Roosen K Acta Neurochir Suppl; 1996; 65():70-2. PubMed ID: 8738500 [TBL] [Abstract][Full Text] [Related]
2. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry. Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919 [TBL] [Abstract][Full Text] [Related]
3. The application of flow cytometry for evaluating biological aggressiveness of intracranial meningiomas. Lin YW; Tai SH; Huang YH; Chang CC; Juan WS; Chao LC; Wen MJ; Hung YC; Lee EJ Cytometry B Clin Cytom; 2015; 88(5):312-9. PubMed ID: 25408130 [TBL] [Abstract][Full Text] [Related]
4. Clinico-pathological correlations in meningiomas: a DNA and immunohistochemical study. Cruz-Sánchez FF; Miquel R; Rossi ML; Figols J; Palacín A; Cardesa A Histol Histopathol; 1993 Jan; 8(1):1-8. PubMed ID: 8443419 [TBL] [Abstract][Full Text] [Related]
5. DNA ploidy and cell-cycle analysis in intracranial meningiomas and hemangiopericytomas: a study with high-resolution DNA flow cytometry. Zellner A; Meixensberger J; Roggendorf W; Janka M; Hoehn H; Roosen K Int J Cancer; 1998 Apr; 79(2):116-20. PubMed ID: 9583723 [TBL] [Abstract][Full Text] [Related]
6. Atypical and anaplastic meningiomas: prognostic implications of clinicopathological features. Yang SY; Park CK; Park SH; Kim DG; Chung YS; Jung HW J Neurol Neurosurg Psychiatry; 2008 May; 79(5):574-80. PubMed ID: 17766430 [TBL] [Abstract][Full Text] [Related]
7. [DNA analysis of meningiomas using paraffin-embedded surgical specimens in connection with clinical recurrence]. Akachi K; Matsumoto M; Yasue M; Nakamura N; Kamada M; Ohno T No Shinkei Geka; 1991 Dec; 19(12):1129-34. PubMed ID: 1766537 [TBL] [Abstract][Full Text] [Related]
8. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics. Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658 [TBL] [Abstract][Full Text] [Related]
9. Correlation of histopathologic classification with proliferative activity and DNA ploidy in 120 intracranial meningiomas, with special reference to atypical meningioma. Myong NH; Chi JG J Korean Med Sci; 1997 Jun; 12(3):221-7. PubMed ID: 9250918 [TBL] [Abstract][Full Text] [Related]
10. Histopathology and MIB-1 labeling index predicted recurrence of meningiomas: a proposal of diagnostic criteria for patients with atypical meningioma. Ho DM; Hsu CY; Ting LT; Chiang H Cancer; 2002 Mar; 94(5):1538-47. PubMed ID: 11920512 [TBL] [Abstract][Full Text] [Related]
11. Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy. Shino A; Nakasu S; Matsuda M; Handa J; Morikawa S; Inubushi T J Neurosurg; 1999 Dec; 91(6):928-34. PubMed ID: 10584837 [TBL] [Abstract][Full Text] [Related]
12. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases. Roser F; Samii M; Ostertag H; Bellinzona M Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263 [TBL] [Abstract][Full Text] [Related]
13. Pathological analyses of early recurrence and malignant transformation in meningiomas. Arai H; Beppu T; Wada T; Yoshida Y; Kubo Y; Suzuki M; Ogawa A Brain Tumor Pathol; 1998; 15(1):37-40. PubMed ID: 9879462 [TBL] [Abstract][Full Text] [Related]
14. Can recurrence of meningiomas be predicted? Kalala JP; Benoit D; De Ridder L Anticancer Res; 2004; 24(4):2319-24. PubMed ID: 15330178 [TBL] [Abstract][Full Text] [Related]
15. Characterization of nuclear DNA content, proliferation index, and nuclear size in a series of 181 meningiomas, including benign primary, recurrent, and malignant tumors. Salmon I; Kiss R; Levivier M; Remmelink M; Pasteels JL; Brotchi J; Flament-Durand J Am J Surg Pathol; 1993 Mar; 17(3):239-47. PubMed ID: 8434704 [TBL] [Abstract][Full Text] [Related]
16. DNA topoisomerase II-alpha and cyclin A immunoexpression in meningiomas and its prognostic significance: an analysis of 263 cases. Korshunov A; Shishkina L; Golanov A Arch Pathol Lab Med; 2002 Sep; 126(9):1079-86. PubMed ID: 12204057 [TBL] [Abstract][Full Text] [Related]
17. Recurrent and atypical meningiomas--a multiparametric study using Ki67 labelling index, AgNOR and DNA Feulgen staining. Ferraraccio F; Accardo M; Giangaspero F; Cuccurullo L Clin Neuropathol; 2003; 22(4):187-92. PubMed ID: 12908755 [TBL] [Abstract][Full Text] [Related]
18. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas. Matsuno A; Fujimaki T; Sasaki T; Nagashima T; Ide T; Asai A; Matsuura R; Utsunomiya H; Kirino T Acta Neuropathol; 1996; 91(5):504-10. PubMed ID: 8740231 [TBL] [Abstract][Full Text] [Related]
19. Clinicopathologic features of aggressive meningioma emphasizing the role of radiotherapy in treatment. Engenhart-Cabillic R; Farhoud A; Sure U; Heinze S; Henzel M; Mennel HD; Bertalanffy H Strahlenther Onkol; 2006 Nov; 182(11):641-6. PubMed ID: 17072521 [TBL] [Abstract][Full Text] [Related]
20. Multiparameter flow cytometric analysis of neoplasms of the central nervous system: correlation of nuclear antigen p105 and DNA content with clinical behavior. Appley AJ; Fitzgibbons PL; Chandrasoma PT; Hinton DR; Apuzzo ML Neurosurgery; 1990 Jul; 27(1):83-96. PubMed ID: 2377285 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]